TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260706. A total of 25 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $3,000 | -40.0% | 14,500 | 0.0% | 0.00% | – |
| Q4 2021 | $5,000 | -44.4% | 14,500 | 0.0% | 0.00% | – |
| Q3 2021 | $9,000 | -96.2% | 14,500 | -93.2% | 0.00% | -100.0% |
| Q2 2021 | $238,000 | -29.8% | 214,500 | -18.9% | 0.00% | -33.3% |
| Q1 2021 | $339,000 | +89.4% | 264,500 | 0.0% | 0.01% | +50.0% |
| Q4 2020 | $179,000 | -19.4% | 264,500 | 0.0% | 0.00% | -20.0% |
| Q3 2020 | $222,000 | +37.9% | 264,500 | 0.0% | 0.01% | +66.7% |
| Q2 2020 | $161,000 | – | 264,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|